The global pharmaceutical industry is converging upon China as a potential market for its innovative medicines. In May 2011, a meeting in Philadelphia will bring together industry thought leaders from the US and China to spotlight the growing opportunities for this innovation to come directly from China. Insight Strategy Advisors has been asked to present at this conference, specifically focusing on the opportunity around localisation to China, and the prospective advantages for pricing and access opportunities.

US – China Pharma™ Innovative Strategies and Partnership Models for R&D Success

The US-China Pharma Conference is expected to guide the attendees through a flow of discussion around potential for innovation in China. The session on localisation advantages, led by Cyrus Chowdhury, Vice President and leader of the Global Market Access practice at Insight Strategy Advisors, explores the opportunities specific to pricing and access.

“Today, many multi-national pharmaceutical companies are approaching China as a market only to promote their own proprietary assets. However, China is not merely a land of customers; rather, it represents an opportunity to develop partnerships with budding innovators as they begin to search for commercialisation prowess in China and beyond her borders,” advises Mr. Chowdhury. “Taking this one step further, these partnerships can have substantial influence over long-term environmental attitudes towards proprietary pipeline and launched products, particularly for access and pricing opportunities.”

“We can look to many other models outside China to understand how these partnerships and localisation investments can improve a brand’s or company’s outlook. As usual, China is a unique case – but it doesn’t mean we can’t learn from our experiences in other markets like Russia and Brazil. Certainly, the Chinese policy-makers will be doing so, as should our industry”

Interested parties can learn more about the opportunity for investment in China, and reciprocal pricing and access advantages by contacting Mr. Chowdhury directly at cyrus.chowdhury@insightstrat.com.

ISA advises on global engagements with an experienced multinational team of consultants headquartered in New York City, with strong presence around the world. Other practice areas include Commercialisation Strategy, Oncology & Specialty Therapeutics, and US Managed Markets.

The Global Market Access practice at Insight Strategy Advisors provides pharmaceutical and biotechnology companies advisory services for maximising market access throughout the global marketplace. Engagements include, but are not limited to, pricing and market access assessments, access influence mapping, portfolio optimisation strategies, partnership due diligence, and NGO facilitation.